Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Tcg Crossover Fund Ii Lp investment portfolio
Tcg Crossover Fund Ii Lp has made numerous investments in companies such as Beacon Therapeutics Holdings, Pheon Therapeutics, and Vicebio within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
| Pheon Therapeutics Ltd Pheon Therapeutics develops next‑generation antibody‑drug conjugates (ADCs) as targeted therapies for hard‑to‑treat cancers. | Healthcare & Life Sciences | Sandwich | Confirmed | 2025-10-19 |
Shareholding changes (3)
Tcg Crossover Fund Ii Lp's positions across portfolio companies2025
- SERIES B 4,084,967 → 8,169,934
- SERIES B2 PREFERRED 7,396,773 → 10,848,600